α- and β-secretase:: profound changes in Alzheimer's disease

被引:152
|
作者
Tyler, SJ
Dawbarn, D
Wilcock, GK
Allen, SJ [1 ]
机构
[1] Univ Bristol, Bristol Royal Infirm, Mol Neurobiol Unit, URCN Care Elderly, Bristol BS2 8HW, Avon, England
[2] Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England
关键词
Alzheimer's disease; alpha-secretase; amyloid; apolipoprotein E; beta-secretase; BACE; choline acetyltransferase; TACE;
D O I
10.1016/S0006-291X(02)02635-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid plaque, a neuropathological hallmark of Alzheimer's disease, is produced by the deposition of beta-amyloid (Abeta) peptide, which is cleaved from Amyloid Precursor Protein (APP) by the enzyme beta-secretase. Only small amounts of Abeta form in normal brain; more typically this is precluded by the processing of APP by alpha-secretase. Here, we describe a decrease in alpha-secretase (81% of normal) and a large increase in beta-secretase activity (185%) in sporadic Alzheimer's disease temporal cortex. Since alpha-secretase is present principally in neurons known to be vulnerable in Alzheimer's disease, and there is known competition between alpha- and beta-secretase for the substrate APP, it is significant that the majority of Alzheimer samples tested here were low in a-secretase. Eighty percent of Alzheimer brains examined had an increase in beta-secretase, a decrease in alpha-secretase, or both; which may account for the means by which the majority of people develop Alzheimer's disease. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [21] Inhibition and modulation of γ-secretase for Alzheimer's disease
    Wolfe, Michael S.
    NEUROTHERAPEUTICS, 2008, 5 (03) : 391 - 398
  • [22] β-secretase as a target for the treatment of Alzheimer's disease
    Citron, M
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 373 - 379
  • [23] Targeting γ-secretase for familial Alzheimer’s disease
    Michael S. Wolfe
    Medicinal Chemistry Research, 2021, 30 : 1321 - 1327
  • [24] γ-Secretase as a Therapeutic Target in Alzheimer's Disease
    Guardia-Laguarta, C.
    Pera, M.
    Lleo, A.
    CURRENT DRUG TARGETS, 2010, 11 (04) : 506 - 517
  • [25] Regulation of γ-secretase activity in Alzheimer's disease
    Zhou, Shuxia
    Zhou, Hua
    Walian, Peter J.
    Jap, Bing K.
    BIOCHEMISTRY, 2007, 46 (10) : 2553 - 2563
  • [26] Secretase inhibitors as therapeutics for Alzheimer's disease
    Olson, RE
    Thompson, LA
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35, 2000, 35 : 31 - 40
  • [27] gamma-Secretase in Alzheimer's disease
    Hur, Ji-Yeun
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, 54 (04): : 433 - 446
  • [28] Amyloid β, γ-secretase, and familial Alzheimer's disease
    Potier, Marie-Claude
    Steiner, Harald
    Chavez-Gutierrez, Lucia
    LANCET NEUROLOGY, 2024, 23 (09): : 852 - 853
  • [29] Therapeutic potential of α-secretase in Alzheimer's disease
    Yang, HQ
    Chen, SD
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2006, 33 (02) : 109 - 115
  • [30] β-Secretase as a therapeutic target for Alzheimer’s disease
    Arun K. Ghosh
    Sandra Gemma
    Jordan Tang
    Neurotherapeutics, 2008, 5 : 399 - 408